The list prices of analogue insulin medicines in the United States have soared during the past decade. In the wake of high-profile cases of prescription medicine “price-gouging”, such as Mylan's EpiPen and Turing-acquired Daraprim, actors across the insulin supply chain are today facing...

Pharmaceutical markets experience the entry of numerous generic firms upon expiration of the brand firm's patent. In this paper, we take a close look at competition among the generic entrants during the first three years after patent expiration and examine whether there is a first mover...

In this paper, we argue that lower prices for pharmaceuticals can be achieved by fostering a new type of competition in the pharmaceutical industry. Lower drug development costs, and hence prices, can be brought about by abolishing national drug administrations and replacing them with private...

This paper argues that drugs are expensive not because of a lack of competition among research-based pharmaceutical companies, but because of a lack of competition in the drug approval process. Lack of competition in the drug approval process has led to exceedingly high drug development costs....

Small and medium enterprises have strengthened their importance during the last decades in most industrialized countries, including the United States, Germany, Japan and Canada. The province of Quebec makes no exception as firms of less than 200 employees generate a substantial portion of its...

Die Ergebnisse der multivariaten Analysen zur Beschäftigungsdynamik und dem Wachstumspotential junger innovativer Unternehmen lassen erkennen, daß junge innovative Unternehmen signifikant höhere Wachstumsraten erzielen als junge Unternehmen mit traditionellen Produkten. Die Abschätzung der...

This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...

This paper analyses the process of knowledge growth in a branch of medical science. Our study of scientific advances in glaucoma research is organized in two parts. In the first we present a qualitative overview of the problem sequences that have characterized 150 years of medical research in...